Haematologica
(Aug 2015)
Proteasome inhibitors block Ikaros degradation by lenalidomide in multiple myeloma
- Chang-Xin Shi,
- Klaus Martin Kortüm,
- Yuan Xiao Zhu,
- Patrick Jedlowski,
- Laura Bruins,
- Esteban Braggio,
- A. Keith Stewart
Affiliations
- Chang-Xin Shi
- Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
- Klaus Martin Kortüm
- Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
- Yuan Xiao Zhu
- Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
- Patrick Jedlowski
- Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
- Laura Bruins
- Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
- Esteban Braggio
- Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
- A. Keith Stewart
- Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA
- DOI
-
https://doi.org/10.3324/haematol.2015.124297
- Journal volume & issue
-
Vol. 100,
no. 8
WeChat QR code